Functional symbiosis between endothelium and epithelial cells in glomeruli

Cell and Tissue Research

Volumn 331, Issue 2, 2008, Pages 485-493

  Hirschberg, Raimund ^a   Wang, Shinong ^a   Mitu, Grace M ^a  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Endothelial cells; Glomerular visceral epithelial cells; Mouse; VEGF

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; GLUCOSE; MATRIGEL; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; GLOMERULUS; MOUSE; NONHUMAN; PERICYTE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SYMBIOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM; GLUCOSE; KIDNEY GLOMERULUS; MICE; PODOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 38349017084     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-007-0526-z     Document Type: Article

References (26)

1. Cogan DG, Toussaint D, Kuwabara T (1961) Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66:366-378
2. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, D'Amore PA (2003) Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 264:275-288
3. Edwards MS, Wilson DB, Craven TE, Stafford J, Fried LF, Wong TY, Klein R, Burke GL, Hansen KJ (2005) Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis 46:214-224
4. Engerman RL (1989) Pathogenesis of diabetic retinopathy. Diabetes 38:1203-1206
5. Fan L, Wakayama T, Yokoyama S, Amano O, Iseki S (2002) Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis. Nephron 90:95-102
6. Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, Pyne K, Mulligan R, Thorpe PE, Dvorak HF, Dvorak AM (2000)Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 48:545-556
7. Gerhardt H, Wolburg H, Redies C (2000) N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev Dyn 218:472-479
8. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP (2006) Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 69:1654-1661
9. Hoshi S, Nomoto K, Kuromitsu J, Tomari S, Nagata M (2002) High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 290:177-184
10. Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H (2005) Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 54:2891-2903
11. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S (2002) Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62:901-913
12. Kawamura H, Kobayashi M, Li Q, Yamanishi S, Katsumura K, Minami M, Wu DM, Puro DG (2004) Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina. J Physiol (Lond) 561:671-683
13. Levidiotis V, Power DA (2005) New insights into the molecular biology of the glomerular filtration barrier and associated disease. Nephrology (Carlton) 10:157-166
14. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77
15. Manaviat MR, Afkhami M, Shoja MR (2004) Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol 4:9
16. Nyengaard JR, Rasch R (1993) The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36:189-194
17. Oishi K, Kamiyashiki T, Ito Y (2007) Isometric contraction of microvascular pericytes from mouse brain parenchyma. Microvasc Res 73:20-28
18. Satchell SC, Harper SJ, Tooke JE, Kerjaschki D, Saleem MA, Mathieson PW (2002) Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 13:544-550
19. Schiwek D, Endlich N, Holzman L, Holthofer H, Kriz W, Endlich K (2004) Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. Kidney Int 66:91-101
20. Shepro D, Morel NM (1993) Pericyte physiology. FASEB J 7:1031-1038
21. Simon M, Rockl W, Hornig C, Grone EF, Theis H, Weich HA, Fuchs E, Yayon A, Grone HJ (1998) Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites. J Am Soc Nephrol 9:1032-1044
22. Singh SK, Behre A, Singh MK (2001) Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus. J Assoc Physicians India 49:439-441
23. Wang S, Caestecker M de, Kopp J, Mitu G, Lapage J, Hirschberg R (2006) Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17:2504-2512
24. White KE, Bilous RW (2004) Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 19:1437-1440
25. Wong TY, Coresh J, Klein R, Muntner P, Couper DJ, Sharrett AR, Klein BE, Heiss G, Hubbard LD, Duncan BB (2004) Retinal microvascular abnormalities and renal dysfunction: The Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 15:2469-2476
26. Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H (2004) Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 53:1831-1840